Meanwhile, E2F1 silencing inhibited tumor cell growth and invasiveness, accompanied by markedly decreased binding of E2F1 at CCND1 and CCNE1 gene promoters in ARID2-depleted cells (Figure 6B–6D). The gene discussed is CCND1; the disease is neoplasm.